NANCY SNOW: Open Payments
NPI 1114682580 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 34 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $902 · 2025 $706
Food & beverage: $674Education: $32
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $138 |
| PFIZER INC. | 4 | $93 |
| ABBVIE INC. | 3 | $78 |
| Otsuka America Pharmaceutical, Inc. | 4 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
| Exact Sciences Corporation | 2 | $47 |
| Corcept Therapeutics | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Novo Nordisk Inc | 2 | $38 |
| Viatris Specialty LLC | 1 | $30 |
Products named: AIRSUPRA, REXULTI, XIFAXAN, Cologuard Collection Kit, NURTEC ODT, Korlym, Auvelity, BREZTRI.
Industry payments across OR — which companies pay providers there.
